What is Applied DNA Sciences Price-to-Operating-Cash-Flow?
As of today (2024-04-27), Applied DNA Sciences's share price is $4.37.
Applied DNA Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-11.23. Hence, Applied DNA Sciences's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Applied DNA Sciences's Price-to-Operating-Cash-Flow or its related term are showing as below:
Applied DNA Sciences's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $-5.49.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-11.23.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 44.90% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 45.60% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 32.30% per year.
During the past 13 years, Applied DNA Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.90% per year. The lowest was -8.60% per year. And the median was 20.75% per year.
Applied DNA Sciences Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Applied DNA Sciences's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied DNA Sciences Price-to-Operating-Cash-Flow Chart
|
Applied DNA Sciences Annual Data
|
|
Trend |
Sep14 |
Sep15 |
Sep16 |
Sep17 |
Sep18 |
Sep19 |
Sep20 |
Sep21 |
Sep22 |
Sep23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
- |
- |
- |
- |
|
Applied DNA Sciences Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Applied DNA Sciences's Price-to-Operating-Cash-Flow
For the Diagnostics & Research subindustry, Applied DNA Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Applied DNA Sciences's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Applied DNA Sciences's Price-to-Operating-Cash-Flow falls into.
Applied DNA Sciences Price-to-Operating-Cash-Flow Calculation
Applied DNA Sciences's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 4.37 | / | -11.231 |
| = | |
Applied DNA Sciences's Share Price of today is $4.37.
Applied DNA Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.23.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Applied DNA Sciences (Applied DNA Sciences) Business Description
Traded in Other Exchanges
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Executives
| Clay Shorrock |
officer: Chief Legal Officer |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Scott L Anchin |
director |
16990 GOLDENTOP ROAD, SUITE A, SAN DIEGO CA 92127 |
| William W Montgomery |
10 percent owner |
34211 SEAVEY LOOP RD., EUGENE OR 97405 |
| Judith Murrah |
officer: Chief Information Officer |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Beth Jantzen |
officer: Chief Financial Officer |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Yacov A Shamash |
director |
|
| Robert B Catell |
director |
62 OSBORNE ROAD, GARDEN CITY NY 11530 |
| John Iii Bitzer |
director |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Joseph D. Ceccoli |
director |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Elizabeth M. Ferguson |
director |
50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Charles S. Ryan |
director |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| James A Hayward |
director, officer: Chief Executive Officer |
C/O 25 HEALTH SCIENCES DRIVE, SUITE 113, NEW YORK NY 11790 |
| Karol Gray |
officer: Chief Financial Officer |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Ming-hwa Benjamin Liang |
officer: Strategic Tech. Dev. Officer |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Yacov Shamash |
director |
100 ENGINEERING, STATE UNIVERSITY OF NY, STONE BROOK NY 117942200 |
Applied DNA Sciences (Applied DNA Sciences) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
APDN has been successfully added to your